Elevated Expression of CHAF1A in Hepatocellular Carcinoma Progression and Immune Modulation
Jiajing Li,1 Ting Zhang,2 Qi Liu,2 Qian Du3 1The Diagnostics Laboratory, Affiliated Hospital to Zunyi Medical University, Zunyi, Guizhou, 563000, People’s Republic of China; 2Affiliated Hospital to Zunyi Medical University, Zunyi, Guizhou, 563000, People’s Republic of China; 3Department of Endoscopy...
Saved in:
| Main Authors: | Li J, Zhang T, Liu Q, Du Q |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Clinical and Experimental Gastroenterology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/elevated-expression-of-chaf1a-in-hepatocellular-carcinoma-progression--peer-reviewed-fulltext-article-CEG |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An oncogene regulating chromatin favors response to immunotherapy<subtitle>Oncogene CHAF1A and immunotherapy outcomes</subtitle>
by: Leqian Ying, et al.
Published: (2024-12-01) -
Identifying key genes involved in HBV-related hepatocellular carcinoma: diagnose, prognosis, interaction and immune analysis
by: Yan Li, et al.
Published: (2025-08-01) -
Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma
by: Yuxuan Li, et al.
Published: (2025-04-01) -
Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model
by: Kuan He, et al.
Published: (2025-08-01) -
A novel telomere-associated genes signature for the prediction of prognosis and treatment responsiveness of hepatocellular carcinoma
by: Kuo Kang, et al.
Published: (2025-02-01)